epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove esrar
    cannabis (Cannabis sativa)
  • remove Primsol
    trimethoprim
  • remove Trimpex
    trimethoprim
  • remove Vyxeos
    daunorubicin/ cytarabine liposomal

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Primsol (trimethoprim) + Vyxeos (daunorubicin/ cytarabine liposomal)

Monitor/Modify Tx


trimethoprim + cytarabine

monitor CBC: combo may incr. risk of myelosuppression (additive effects)

trimethoprim + daunorubicin

monitor CBC, bleeding signs/symptoms: combo may incr. risk of myelosuppression, bleeding, including life-threatening (additive effects)

Smiley face Smiley face Trimpex (trimethoprim) + Vyxeos (daunorubicin/ cytarabine liposomal)

Monitor/Modify Tx


trimethoprim + cytarabine

monitor CBC: combo may incr. risk of myelosuppression (additive effects)

trimethoprim + daunorubicin

monitor CBC, bleeding signs/symptoms: combo may incr. risk of myelosuppression, bleeding, including life-threatening (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information